News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
299,565 Results
Type
Article (14546)
Company Profile (102)
Press Release (284917)
Multimedia
Podcasts (47)
Webinars (10)
Section
Business (97415)
Career Advice (472)
Deals (17438)
Drug Delivery (67)
Drug Development (39928)
Employer Resources (49)
FDA (7080)
Job Trends (6562)
News (166225)
Policy (15487)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (502)
Accelerated approval (2)
Adcomms (6)
Allergies (35)
Alliances (26663)
ALS (41)
Alzheimer's disease (456)
Antibody-drug conjugate (ADC) (47)
Approvals (7125)
Artificial intelligence (114)
Autoimmune disease (9)
Automation (4)
Bankruptcy (151)
Best Places to Work (4668)
BIOSECURE Act (9)
Biosimilars (62)
Biotechnology (42)
Bladder cancer (24)
Brain cancer (18)
Breast cancer (93)
Cancer (727)
Cardiovascular disease (75)
Career advice (415)
Career pathing (12)
CAR-T (24)
Cell therapy (105)
Cervical cancer (4)
Clinical research (33675)
Collaboration (385)
Compensation (158)
Complete response letters (17)
COVID-19 (863)
CRISPR (20)
C-suite (129)
Cystic fibrosis (41)
Data (728)
Denatured (15)
Depression (10)
Diabetes (90)
Diagnostics (1787)
Digital health (1)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (64)
Drug pricing (65)
Drug shortages (12)
Duchenne muscular dystrophy (46)
Earnings (35779)
Editorial (12)
Employer branding (4)
Employer resources (43)
Events (41455)
Executive appointments (409)
FDA (7578)
Featured Employer (20)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (247)
Gene editing (40)
Generative AI (9)
Gene therapy (115)
GLP-1 (363)
Government (1424)
Grass and pollen (4)
Guidances (18)
Healthcare (4186)
Huntington's disease (4)
IgA nephropathy (12)
Immunology and inflammation (34)
Indications (16)
Infectious disease (902)
Inflammatory bowel disease (61)
Inflation Reduction Act (6)
Influenza (18)
Intellectual property (52)
Interviews (59)
IPO (6749)
IRA (29)
Job creations (2130)
Job search strategy (380)
Kidney cancer (6)
Labor market (12)
Layoffs (182)
Leadership (3)
Legal (3784)
Liver cancer (30)
Lung cancer (100)
Lymphoma (60)
Machine learning (1)
Management (16)
Manufacturing (177)
MASH (35)
Medical device (2245)
Medtech (2248)
Mergers & acquisitions (10942)
Metabolic disorders (284)
Multiple sclerosis (27)
NASH (14)
Neurodegenerative disease (29)
Neuropsychiatric disorders (8)
Neuroscience (664)
NextGen: Class of 2025 (1697)
Non-profit (631)
Northern California (777)
Now hiring (8)
Obesity (160)
Opinion (120)
Ovarian cancer (21)
Pain (52)
Pancreatic cancer (21)
Parkinson's disease (52)
Partnered (7)
Patents (121)
Patient recruitment (35)
Peanut (10)
People (30855)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8935)
Phase II (14350)
Phase III (12568)
Pipeline (503)
Policy (71)
Postmarket research (1447)
Preclinical (3581)
Press Release (27)
Prostate cancer (50)
Psychedelics (8)
Radiopharmaceuticals (132)
Rare diseases (176)
Real estate (2907)
Recruiting (17)
Regulatory (11176)
Reports (16)
Research institute (602)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (2)
RSV (8)
Schizophrenia (39)
Series A (43)
Series B (16)
Service/supplier (4)
Sickle cell disease (32)
Southern California (817)
Special edition (6)
Spinal muscular atrophy (79)
Sponsored (6)
Startups (1847)
State (2)
Stomach cancer (4)
Supply chain (33)
Tariffs (26)
The Weekly (30)
United States (7949)
Vaccines (170)
Venture capitalists (14)
Weight loss (100)
Women's health (9)
Worklife (3)
Date
Today (47)
Last 7 days (230)
Last 30 days (987)
Last 365 days (13167)
2025 (4042)
2024 (14064)
2023 (16100)
2022 (22800)
2021 (23374)
2020 (21936)
2019 (16683)
2018 (13051)
2017 (15468)
2016 (14650)
2015 (17260)
2014 (13928)
2013 (11943)
2012 (12848)
2011 (13344)
2010 (12125)
Location
Africa (338)
Alabama (14)
Alaska (1)
Arizona (56)
Arkansas (3)
Asia (30939)
Australia (4009)
California (1913)
Canada (1007)
China (306)
Colorado (71)
Connecticut (76)
Delaware (58)
Europe (45649)
Florida (334)
Georgia (40)
Idaho (9)
Illinois (203)
India (19)
Indiana (135)
Iowa (1)
Japan (127)
Kansas (61)
Kentucky (12)
Louisiana (2)
Maine (5)
Maryland (316)
Massachusetts (1618)
Michigan (32)
Minnesota (118)
Missouri (26)
Montana (8)
Nebraska (6)
Nevada (8)
New Hampshire (6)
New Jersey (851)
New Mexico (7)
New York (600)
North Carolina (424)
North Dakota (2)
Northern California (777)
Ohio (51)
Oklahoma (4)
Oregon (17)
Pennsylvania (477)
Puerto Rico (8)
Rhode Island (10)
South America (553)
South Carolina (2)
Southern California (817)
Tennessee (34)
Texas (252)
Utah (44)
Virginia (75)
Washington D.C. (31)
Washington State (131)
Wisconsin (17)
299,565 Results for "faron pharmaceuticals ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Faron Announces Acceptance of Bexmarilimab Phase II Data for Oral Presentation at ASCO 2025
April 24, 2025
·
4 min read
Press Releases
Inside Information: Faron Announces Positive Phase II Results in Higher-risk Myelodysplastic Syndrome
April 15, 2025
·
4 min read
Genetown
Faron Founders and bexmarilimab Developers Selected as Finalists for the European Inventor Award 2024
Faron Pharmaceuticals Ltd. announces the nomination of its co-founders, Dr. Markku Jalkanen and Dr. Sirpa Jalkanen, as finalists in the ‘SMEs’ category of the European Inventor Award 2024.
May 16, 2024
·
5 min read
Genetown
Faron Pharmaceuticals Ltd Results of the Extraordinary General Meeting - September 22, 2023
Faron Pharmaceuticals Ltd. announces that the extraordinary general meeting of the Company took place , September 22, 2023 in Turku, Finland.
September 22, 2023
·
4 min read
Business
Faron’s Financial Statement Release January 1 to December 31, 2023
Faron Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on tackling cancers via novel myeloid cell targeted immunotherapies, announced audited full-year financial results for January 1 to December 31, 2023 and provided an overview of recent corporate developments.
March 13, 2024
·
40 min read
Business
Faron Confirms Plans for the Coming Months Under New Leadership - April 16, 2024
Faron Pharmaceuticals Ltd. announces ongoing plans and activities for the coming months following the recent announcement of the proposed appointment of Dr. Juho Jalkanen as Chief Executive Officer, effective 1 May 2024.
April 16, 2024
·
3 min read
Genetown
Faron Pharmaceuticals Ltd. to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Faron Pharmaceuticals Ltd. announces that Dr Markku Jalkanen, PhD, CEO will present at the H.C. Wainwright Annual Global Investment Conference in New York City on September 12, 2023.
September 6, 2023
·
1 min read
Drug Development
Faron to Host Webcast to Discuss latest data from Phase 1 part of the BEXMAB Study of Bexmarilimab
Faron Pharmaceuticals Ltd. announces it will host a virtual BEXMAB update event on Tuesday, March 19 at 11.00 EET/9am GMT, following the most recent data cut-off and scheduled analysis.
March 14, 2024
·
5 min read
Business
Faron Pharmaceuticals Notice of Half-Year Financial Results
Faron Pharmaceuticals Ltd will report its unaudited half-year financial results for the six months ended June 30, 2023, on Tuesday, August 29, 2023.
August 4, 2023
·
5 min read
Business
Faron Pharmaceuticals Announces Board Changes - September 22, 2023
Faron Pharmaceuticals Ltd. is pleased to announce the appointment of Ms. Christine Roth and Dr. Marie-Louise Fjällskog as Non-Executive Directors of the Company with immediate effect following the passing of all resolutions put to shareholders of the Company at the Extraordinary General Meeting held earlier.
September 22, 2023
·
7 min read
1 of 29,957
Next
